Back to Search Start Over

709P Cabozantinib (C) in combination with atezolizumab (A) in non-clear cell renal cell carcinoma (nccRCC): Results from cohort 10 of the COSMIC-021 study.

Authors :
McGregor, B.A.
Agarwal, N.
Suarez, C.
Tsao, C-K.
Kelly, W.
Pagliaro, L.
Vaishampayan, U.N.
Castellano, D.
Loriot, Y.
Werneke, S.
Curran, D.
Choueiri, T.K.
Pal, S.
Source :
Annals of Oncology. 2020 Supplement 4, Vol. 31, pS558-S558. 1p.
Publication Year :
2020

Subjects

Subjects :
*RENAL cell carcinoma
*ATEZOLIZUMAB

Details

Language :
English
ISSN :
09237534
Volume :
31
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
152695316
Full Text :
https://doi.org/10.1016/j.annonc.2020.08.781
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details